glp 1 dehydration on a GLP-1 is a bigger deal than people realize. On a GLP-1, being even a little under-hydrated can feel like absolute death—and here’s why 👇 1️⃣ Slower gastric emptying GLP-1s already If you're on a GLP-1

Coverage is not universal and varies by plan

In the New England Journal of Medicine, Garvey and colleagues [5] report the results of the REDEFINE 1 trial, a 68-week, phase 3a double-blind, placebo-controlled and active-controlled trial evaluating the efficacy and safety of coadministered cagrilintide and semaglutide in adults with obesity [body mass index (BMI) 30 kg/m 2 ] or overweight (BMI 27 kg/m 2 ) with at least one weight-related comorbidity

Semaglutide: Targets the GLP-1 pathway only Focuses on appetite regulation and fullness Tirzepatide: Targets both GLP-1 and GIP pathways May create a broader metabolic response Although this difference sounds technical, it can influence how patients respond to treatment

Researchers interested in peptide purity testing, laboratory handling, HPLC peptide analysis, LC-MS verification, peptide storage recommendations, quality control, and scientific laboratory methodologies are encouraged to browse our Research Peptide Guides

Rachele, Restores Chief Science Officer, adds